# Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction

> **NCT01536015** · PHASE3 · TERMINATED · sponsor: **UCB Pharma** · enrollment: 25 (actual)

## Conditions studied

- Advanced Parkinson's Disease

## Interventions

- **DRUG:** Rotigotine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01536015
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** The study was stopped due to low enrollment.
- **Last updated:** 2014-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01536015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01536015, "Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01536015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*